Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9004907 | Biomedicine & Pharmacotherapy | 2005 | 6 Pages |
Abstract
Results. - Our results show a dose-related decrease of MMP-2 mRNA and protein levels 72Â h after resveratrol treatment, and lower SPARC gene and protein expression 72Â h after resveratrol treatment. This indicates that resveratrol may influence the two major factors in the ECM remodeling occurring with tumor invasion, suggesting it may have uses as a therapeutic agent for brain tumors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicoletta Gagliano, Claudia Moscheni, Carlo Torri, Ivana Magnani, Alberto A. Bertelli, Magda Gioia,